ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0004924 | abnormal behavior |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * CD-1 | color key |
MP:0002576 | abnormal enamel morphology |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd | color key |
MP:0003656 | abnormal erythrocyte physiology |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0011320 | abnormal glomerular capillary morphology |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0011339 | abnormal glomerular mesangium morphology |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0010096 | abnormal incisor color |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd | color key |
MP:0005637 | abnormal iron homeostasis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd | color key |
MP:0001770 | abnormal iron level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd | color key |
MP:0003628 | abnormal leukocyte adhesion |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0000609 | abnormal liver physiology |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0002451 | abnormal macrophage physiology |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0003871 | abnormal myelin sheath morphology |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0008872 | abnormal physiological response to xenobiotic |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0008872 | abnormal physiological response to xenobiotic |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0005325 | abnormal renal glomerulus morphology |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0002133 | abnormal respiratory system physiology |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0008737 | abnormal spleen physiology |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0009333 | abnormal splenocyte physiology |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0002100 | abnormal tooth morphology |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd | color key |
MP:0002100 | abnormal tooth morphology |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0010177 | acanthocytosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0000129 | ameloblast degeneration |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd | color key |
MP:0002642 | anisocytosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0003354 | astrocytosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0005150 | cachexia |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001394 | circling |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * CD-1 | color key |
MP:0008075 | decreased CD4-positive T cell number |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0005018 | decreased T cell number |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0008642 | decreased circulating interleukin-1 beta level |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0005558 | decreased creatinine clearance |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0002875 | decreased erythrocyte cell number |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0000208 | decreased hematocrit |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0002874 | decreased hemoglobin content |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0004001 | decreased hepatocyte proliferation |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0005517 | decreased liver regeneration |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0003402 | decreased liver weight |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0003179 | decreased platelet cell number |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0004882 | enlarged lung |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ * C57BL | color key |
MP:0000702 | enlarged lymph nodes |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0000691 | enlarged spleen |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0011506 | glomerular crescent |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0002743 | glomerulonephritis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0005264 | glomerulosclerosis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0001585 | hemolytic anemia |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0002628 | hepatic steatosis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0000189 | hypoglycemia |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0002493 | increased IgG level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0002494 | increased IgM level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0005088 | increased acute inflammation |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * CD-1 | color key |
MP:0004762 | increased anti-double stranded DNA antibody level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0004794 | increased anti-nuclear antigen antibody level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0006042 | increased apoptosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0008406 | increased cellular sensitivity to hydrogen peroxide |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0006060 | increased cerebral infarction size |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * CD-1 | color key |
MP:0002941 | increased circulating alanine transaminase level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0005344 | increased circulating bilirubin level |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0008641 | increased circulating interleukin-1 beta level |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0008596 | increased circulating interleukin-6 level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0008553 | increased circulating tumor necrosis factor level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0003887 | increased hepatocyte apoptosis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0004499 | increased incidence of chemically-induced tumors |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0011440 | increased kidney cell proliferation |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0002944 | increased lactate dehydrogenase level |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0008807 | increased liver iron level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd | color key |
MP:0005630 | increased lung weight |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0005425 | increased macrophage cell number |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0010178 | increased number of Howell-Jolly bodies |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0008873 | increased physiological sensitivity to xenobiotic |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ * C57BL | color key |
MP:0009766 | increased sensitivity to xenobiotic induced morbidity/mortality |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0009766 | increased sensitivity to xenobiotic induced morbidity/mortality |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ * C57BL | color key |
MP:0004952 | increased spleen weight |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0004952 | increased spleen weight |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0009322 | increased splenocyte apoptosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0010301 | increased stomach tumor incidence |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0004821 | increased susceptibility to experimental autoimmune uveoretinitis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0008537 | increased susceptibility to induced colitis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0003076 | increased susceptibility to ischemic brain injury |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * CD-1 | color key |
MP:0002962 | increased urine protein level |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0001860 | liver inflammation |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001182 | lung hemorrhage |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ * C57BL | color key |
MP:0001861 | lung inflammation |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0011427 | mesangial cell hyperplasia |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0003674 | oxidative stress |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0003674 | oxidative stress |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0003674 | oxidative stress |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0002643 | poikilocytosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0002083 | premature death |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0006050 | pulmonary fibrosis |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |
MP:0002640 | reticulocytosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0000314 | schistocytosis |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0002654 | spongiform encephalopathy |
Nfe2l2tm1Ywk |
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk | involves: 129X1/SvJ | color key |
MP:0001263 | weight loss |
Nfe2l2tm1Mym |
Nfe2l2tm1Mym/Nfe2l2tm1Mym | involves: 129P2/OlaHsd * ICR | color key |